ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
Dow Jones
42.732,13
0,80%
Euro vs US Dollar
1,02973
-0,07%
Bitcoin
98.273,40
-0,03%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. GRAIL Inc (GRAL) Börsenkurse

GRAIL Inc

GRAIL Inc (GRAL)

Grifal SpA
19,45
1,53
(8,54%)
Beim Schlusskurs: 06 Januar 10:00PM
Verzögert um 15 Minuten
19,01
-0,44
( -2,26% )
Nach Börsenschluss: 11:51PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
19,01
Gebot
15,37
Fragen
21,18
Volumen
413.798
17,835 Tagesbereich 19,45
12,33 52-Wochen-Bereich 24,92
Marktkapitalisierung
638,751M
Handelsende
17,92
Handelsbeginn
18,00
Letzte Trade
1
@
19.01
Letzter Handelszeitpunkt
Finanzvolumen
US$ 7.801.523
VWAP
18,8535
Durchschnittliches Volumen (3 Mio.)
796.665
Ausgegebene Aktien
33.600.772
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,45
Gewinn pro Aktie (EPS)
-43,62
Erlöse
93,11M
Nettogewinn
-1,47B

Über GRAIL Inc

GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable. GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable.

Sektor
Medical Laboratories
Branche
Medical Laboratories
Website
grail.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
GRAIL Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker GRAL. The last closing price for GRAIL was US$17,92. Over the last year, GRAIL shares have traded in a share price range of US$ 12,33 to US$ 24,92.

GRAIL currently has 33.600.772 shares in issue. The market capitalisation of GRAIL is US$602,13 million. GRAIL has a price to earnings ratio (PE ratio) of -0.45.

GRAL Neueste Nachrichten

Weitere Nachrichten

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire MENLO PARK, Calif., Dec. 18, 2024 MENLO PARK, Calif., Dec. 18, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a...

18 Dezember 2024
PR Newswire (US)

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire MENLO PARK, Calif., Dec. 3, 2024 MENLO PARK, Calif., Dec. 3, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a...

03 Dezember 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

19 November 2024
Edgar (US Regulatory)

GRAIL to Participate in Upcoming Investor Conferences

GRAIL to Participate in Upcoming Investor Conferences PR Newswire MENLO PARK, Calif., Nov. 19, 2024 MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare...

19 November 2024
PR Newswire (US)

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study PR Newswire MENLO PARK, Calif., Nov. 18, 2024 MENLO PARK, Calif., Nov. 18, 2024 ...

18 November 2024
PR Newswire (US)

Form 144 - Report of proposed sale of securities

16 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 November 2024
Edgar (US Regulatory)

GRAIL Reports Third Quarter 2024 Financial Results

GRAIL Reports Third Quarter 2024 Financial Results PR Newswire MENLO PARK, Calif., Nov. 12, 2024 Galleri Revenue Grew 52% Year-Over-Year to $25.4 Million Commercial Galleri Sales Surpassed...

12 November 2024
PR Newswire (US)

Form 8-K - Current report

12 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.44-2.2622107969219.4520.058617.44553069518.35478837CS
4-3.6-15.92215833722.6124.9216.105105125219.46613254CS
125.6342.077727952213.3824.9212.7679666517.44869685CS
263.9626.312292358815.0524.9212.3392073316.10006823CS
520.382.039720880318.6324.9212.33109332816.10423927CS
1560.382.039720880318.6324.9212.33109332816.10423927CS
2600.382.039720880318.6324.9212.33109332816.10423927CS

GRAL - Frequently Asked Questions (FAQ)

What is the current GRAIL share price?
The current share price of GRAIL is US$ 19,01
How many GRAIL shares are in issue?
GRAIL has 33.600.772 shares in issue
What is the market cap of GRAIL?
The market capitalisation of GRAIL is USD 602,13M
What is the 1 year trading range for GRAIL share price?
GRAIL has traded in the range of US$ 12,33 to US$ 24,92 during the past year
What is the PE ratio of GRAIL?
The price to earnings ratio of GRAIL is -0,45
What is the cash to sales ratio of GRAIL?
The cash to sales ratio of GRAIL is 7,02
What is the reporting currency for GRAIL?
GRAIL reports financial results in USD
What is the latest annual turnover for GRAIL?
The latest annual turnover of GRAIL is USD 93,11M
What is the latest annual profit for GRAIL?
The latest annual profit of GRAIL is USD -1,47B
What is the registered address of GRAIL?
The registered address for GRAIL is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the GRAIL website address?
The website address for GRAIL is grail.com
Which industry sector does GRAIL operate in?
GRAIL operates in the MEDICAL LABORATORIES sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,8M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,08M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,62M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
155,16k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
967,95k
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,4M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,5M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230,01M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
GRAL
GRAIL
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten